We demonstrate that these subtypes can be differentiated immunologically in skeletal muscle biopsies from ACTA1 nemaline myopathy patients, potentially providing markers for disease severity and aiding in the identification of the causative mutation. The gene discussed is ACTA1; the disease is myopathy.